Orchestra BioMed (OBIO) Institutional Ownership → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free OBIO Stock Alerts $4.39 -0.05 (-1.13%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)CurrentInstitutional OwnershipPercentage53.55%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$106.68MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.65M Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OBIO Institutional Buying and Selling by Quarter Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Orchestra BioMed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010% 10/27/2023 Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014% 10/27/2023TD Asset Management Inc92,678$808K0.0%+100.0%0.259% 10/24/2023Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113% 10/18/2023UMB Bank n.a.3,160$28K0.0%N/A0.009% 10/13/2023Arkadios Wealth Advisors51,595$450K0.0%N/A0.144% 8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744% 8/11/2023Atika Capital Management LLC64,651$453K0.0%N/A0.181% 5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230% 5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652% 4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027% (Data available from 1/1/2016 forward) OBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OBIO shares? During the previous two years, 11 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($100.17M), Perceptive Advisors LLC ($14.37M), Boxer Capital LLC ($4.89M), TD Asset Management Inc ($808K), Atika Capital Management LLC ($453K), Arkadios Wealth Advisors ($450K), and Bank of New York Mellon Corp ($351K).Learn more on OBIO's institutional investors. What percentage of Orchestra BioMed stock is owned by institutional investors? 53.55% of Orchestra BioMed stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings. Which institutional investors have been buying Orchestra BioMed stock? Of the 9 institutional investors that purchased Orchestra BioMed stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($5.12M), Boxer Capital LLC ($250K), Atika Capital Management LLC ($64.65K), Arkadios Wealth Advisors ($51.60K), TD Asset Management Inc ($46.34K), Bank of New York Mellon Corp ($27.34K), and Allspring Global Investments Holdings LLC ($4.90K). How much institutional buying is happening at Orchestra BioMed? Institutional investors have bought a total of 5,569,480 shares in the last 24 months. This purchase volume represents approximately $106.74M in transactions. Which Orchestra BioMed major shareholders have been selling company stock? The following institutional investors have sold Orchestra BioMed stock in the last 24 months: Perceptive Advisors LLC ($225.36K), and New York State Common Retirement Fund ($7.93K). How much institutional selling is happening at Orchestra BioMed? Institutional investors have sold a total of 233,289 shares in the last 24 months. This volume of shares sold represents approximately $1.65M in transactions. Related Companies: QIPT Institutional Ownership CLPT Institutional Ownership DRTS Institutional Ownership PROF Institutional Ownership TELA Institutional Ownership STIM Institutional Ownership DCTH Institutional Ownership ALUR Institutional Ownership ARAY Institutional Ownership INO Institutional Ownership This page (NASDAQ:OBIO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
